A28 Therapeutics

Developer of targeted oncolytic peptides for cancer treatment

Not yet rated

InstitutionVisit websiteWebsite

Represent A28 Therapeutics?

Claim to manage & get analytics

Rankings

—Hospitals & Healthcare

View alternatives →Best Hospitals & Healthcare →

Added 10 Jul 2026

Edited 22 Jul 2026 by Admin · history

Is this page accurate?

Suggest edit →

Rankings

#Hospitals & Healthcare

A28 Therapeutics is a clinical-stage biopharmaceutical company that specializes in the development of targeted oncolytic peptides (TOPs) for treating various types of cancer. The company's lead compound, AT-101, has been clinically tested through a Phase 2a study and demonstrates an attractive safety profile and promising anti-tumor activity. A28 Therapeutics' technology platform has been the subject of over 70 pre-clinical studies.

Reviews

Your slider rating is attached automatically. Write about your experience to help others decide.

No reviews yet. Be the first to share your experience.

🇺🇸Headquartered inUnited States

Address

United States, United States

Available in

🇺🇸United States

Is this page accurate?

Suggest edit →

Represent A28 Therapeutics?

Claim to manage, respond to reviews & get analytics

Scores and rankings reflect aggregated community opinion and are not editorial assessments by Peakd. Entity information (descriptions, images, links, pricing) may be sourced from automated tools or community contributions and is not guaranteed to be accurate or up-to-date. Peakd does not endorse, verify, or guarantee the accuracy of any content. Represent this entity? Claim this page to manage it. · Terms · Removal requests

Rankings

#Hospitals & Healthcare

Reviews

Your slider rating is attached automatically. Write about your experience to help others decide.

No reviews yet. Be the first to share your experience.

A28 Therapeutics

Rankings

Reviews

Address

Available in

Rankings

Reviews

Links

Sources

Address

Available in